Oppenheimer analyst Jason Helfstein maintains $Lemonade (LMND.US)$ with a hold rating.
According to TipRanks data, the analyst has a success rate of 51.2% and a total average return of 11.0% over the past year.
Furthermore, according to the comprehensive report, the opinions of $Lemonade (LMND.US)$'s main analysts recently are as follows:
Lemonade outlined an ambitious objective during its investor day, aiming to increase its business from $1 billion in premiums to $10 billion over the upcoming years. The company is also aiming to reach net profit positive by the end of 2027, a timeline that is significantly more optimistic than the consensus estimates. Analysts believe that the next phase of Lemonade's growth will be fueled by its distinctive technology.
The firm is adjusting its valuation approach to include a future capital raise, though the new higher target price implies a less dilutive raise owing to the recent increase in stock price.
Note:
TipRanks, an independent third party, provides analysis data from financial analysts and calculates the Average Returns and Success Rates of the analysts' recommendations. The information presented is not an investment recommendation and is intended for informational purposes only.
Success rate is the number of the analyst's successful ratings, divided by his/her total number of ratings over the past year. A successful rating is one based on if TipRanks' virtual portfolio earned a positive return from the stock. Total average return is the average rate of return that the TipRanks' virtual portfolio has earned over the past year. These portfolios are established based on the analyst's preliminary rating and are adjusted according to the changes in the rating.
TipRanks provides a ranking of each analyst up to 5 stars, which is representative of all recommendations from the analyst. An analyst's past performance is evaluated on a scale of 1 to 5 stars, with more stars indicating better performance. The star level is determined by his/her total success rate and average return.
